Publication | Closed Access
MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection
55
Citations
0
References
2017
Year
HepatologyKidney TransplantHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyLiver DiseaseAntiviral DrugLiver TransplantationMedicineAutoimmune Liver DiseaseRenal Transplant Adults
No additional data available for this publication yet. Check back later!